Patient Retention in Clinical Trials

Patient retention is a critical component of successful clinical trials. High retention rates ensure the integrity of trial data and the reliability of study outcomes. When patients remain engaged and continue their participation throughout the duration of a clinical trial, researchers can gather comprehensive and accurate data, ultimately leading to the development of effective treatments and therapies.


This blog aims to explore the significance of patient retention in clinical trials and provide actionable strategies to maintain patient engagement and retention from start to finish. By understanding and implementing these strategies, researchers and trial coordinators can enhance the overall success and reliability of their clinical studies.


Understanding Patient Retention


Patient retention refers to the ability of a clinical trial to keep participants engaged and enrolled for the entire duration of the study. High retention rates are crucial for ensuring that the data collected is comprehensive, reliable, and statistically significant. When patients remain in the study until its completion, researchers can gather consistent data, which is essential for evaluating the efficacy and safety of the treatment being tested.


Common Reasons for Patient Dropout:


Understanding why patients leave clinical trials can help in developing strategies to improve retention. Common reasons for patient dropout include:


  • Adverse Side Effects: Experiencing severe or unexpected side effects can lead participants to withdraw from the trial.
  • Lack of Understanding: Participants may not fully understand the trial process, leading to confusion and disengagement.
  • Time Commitment: The time required for visits, treatments, and follow-ups can be a significant burden.
  • Transportation and Accessibility: Difficulties in getting to the trial site can deter continued participation.
  • Lack of Communication: Insufficient communication from the trial coordinators can result in participants feeling neglected or uninformed.


Consequences of Low Retention Rates on Clinical Trial Outcomes


Low retention rates can severely impact the validity and success of a clinical trial. Consequences include:


  • Inconclusive Results: Insufficient data due to high dropout rates can lead to inconclusive or unreliable results.
  • Increased Costs: More resources are needed to recruit additional participants to replace those who drop out, increasing the overall cost of the trial.
  • Regulatory Challenges: Trials with high dropout rates may face difficulties in gaining regulatory approval due to concerns about data integrity.
  • Delayed Progress: Low retention can slow down the development process of new treatments, delaying their availability to patients in need.


By addressing the factors that contribute to patient dropout and implementing effective retention strategies, clinical trials can improve their retention rates, leading to more successful and impactful research outcomes.


Building a Patient-Centric Trial Design


Simplifying Trial Protocols and Procedures


One of the most effective ways to improve patient retention is by simplifying the trial protocols and procedures. Complex and time-consuming requirements can deter participants from continuing with the study. Streamlining these processes can include:


  • Reducing the Number of Visits: Minimizing the frequency of clinic visits and incorporating remote monitoring when possible.
  • Simplifying Consent Forms: Using clear, concise language in consent documents to ensure participants fully understand their commitments.
  • Streamlining Data Collection: Implementing user-friendly tools for data collection, such as mobile apps or telemedicine platforms.


Reducing Patient Burden and Inconvenience


Addressing the logistical and practical challenges that participants face can significantly enhance retention rates. Strategies to reduce patient burden include:


  • Providing Transportation Assistance: Offering transportation services or reimbursement for travel expenses to ensure participants can easily access trial sites.
  • Flexible Scheduling: Allowing for flexible appointment times to accommodate participants' work and personal schedules.
  • Home Visits and Remote Monitoring: Utilizing home visits by medical professionals or remote monitoring technology to reduce the need for frequent clinic visits.


Incorporating Patient Feedback in Trial Design


Involving patients in the trial design process can help ensure that their needs and concerns are addressed, leading to higher satisfaction and retention. Ways to incorporate patient feedback include:


  • Patient Advisory Boards: Establishing advisory boards composed of current and former trial participants to provide insights and suggestions for improving the trial experience.
  • Surveys and Focus Groups: Conducting surveys and focus groups with potential and enrolled participants to gather feedback on trial procedures, materials, and communication.
  • Iterative Design Process: Continuously improving trial protocols based on participant feedback, ensuring that the trial design remains patient-friendly and responsive to their needs.


By prioritizing a patient-centric approach in trial design, clinical trials can become more accessible, engaging, and accommodating for participants. This not only improves retention rates but also enhances the overall quality and success of the trial.


Effective Communication Strategies


Effective communication is crucial for maintaining patient engagement and retention throughout a clinical trial. Clear and consistent communication helps build trust, ensures patients understand their role and the trial's progress, and addresses any concerns they may have. Strategies for effective communication include:


  • Transparency: Being open about trial progress, potential risks, and benefits.
  • Consistency: Providing regular updates to keep patients informed and engaged.


Regular Updates and Check-Ins with Patients


Keeping participants regularly informed about the trial's status, their individual progress, and any relevant developments is essential. This can be achieved through:


  • Scheduled Check-Ins: Regular phone calls, emails, or in-person visits to discuss the patient's experience and address any issues.
  • Progress Reports: Sharing updates about the trial's progress, including milestones achieved and any changes to the protocol.
  • Reminders: Sending reminders for upcoming appointments, medication schedules, and other trial-related activities to ensure patients stay on track.


Providing Educational Materials and Resources


Educating patients about the clinical trial process, the condition being studied, and the treatment they are receiving can help improve their understanding and commitment to the trial. Resources may include:


  • Informational Brochures: Easy-to-read materials that explain the trial, its goals, and what patients can expect.
  • Webinars and Workshops: Interactive sessions where patients can learn more about the trial and ask questions.
  • Access to Experts: Opportunities for patients to speak with doctors, researchers, or patient advocates to gain deeper insights and reassurance.


By prioritizing clear, consistent, and educational communication, clinical trial teams can foster a positive relationship with participants, reducing dropout rates and enhancing overall trial success.


Enhancing the Participant Experience


Creating a Supportive and Welcoming Trial Environment


Ensuring that participants feel valued and supported throughout the clinical trial is critical for retention. This involves:


  • Friendly Staff: Training staff to be approachable, empathetic, and responsive to patient needs.
  • Comfortable Facilities: Providing a comfortable and welcoming environment at trial sites.
  • Patient Recognition: Acknowledging and appreciating participants' contributions to the research.


Offering Flexible Scheduling and Location Options


Flexibility can significantly improve patient retention by accommodating their busy schedules and personal commitments. Strategies include:


  • Flexible Appointment Times: Offering appointments outside regular business hours, including evenings and weekends.
  • Multiple Locations: Providing the option to attend trial visits at different sites or through mobile clinics to reduce travel burdens.
  • Telehealth Options: Utilizing telemedicine for certain trial visits and consultations, allowing patients to participate from home.


Providing Additional Support Services (e.g., Transportation, Childcare)


Additional support services can alleviate common barriers to participation, making it easier for patients to stay engaged in the trial. Examples include:


  • Transportation Services: Offering rides to and from trial sites for patients without reliable transportation.
  • Childcare Services: Providing childcare during trial visits to help parents participate without worry.
  • Financial Support: Covering out-of-pocket expenses related to trial participation, such as travel costs, meals, and accommodation if necessary.


By focusing on enhancing the participant experience through support, flexibility, and recognition, clinical trials can improve patient satisfaction and retention rates, ultimately leading to more successful and reliable outcomes.


Utilizing Technology for Engagement


Leveraging Digital Tools for Patient Monitoring and Communication


Incorporating digital tools can streamline communication and monitoring, enhancing patient engagement and retention. Key strategies include:


  • Wearable Devices: Using wearables to monitor patients' health metrics in real-time and provide continuous data.
  • Patient Portals: Creating secure online portals where patients can access their trial information, communicate with the study team, and receive updates.
  • Automated Reminders: Setting up automated reminders for appointments, medication schedules, and follow-ups to keep patients on track.


Using Mobile Apps for Reminders, Progress Tracking, and Virtual Visits


Mobile apps can be a powerful tool for maintaining patient engagement throughout the trial. Features to include:


  • Reminders and Alerts: Sending push notifications for upcoming visits, medication doses, and important trial-related activities.
  • Progress Tracking: Allowing patients to track their progress, log symptoms, and view their health data in real-time.
  • Virtual Visits: Enabling virtual consultations and check-ins through the app, reducing the need for in-person visits and increasing convenience for patients.


Implementing Telemedicine for Remote Consultations and Follow-Ups


Telemedicine can enhance patient retention by offering flexibility and convenience. Implementation strategies include:


  • Video Consultations: Conducting regular follow-ups and consultations via video calls to reduce travel time and inconvenience.
  • Remote Monitoring: Using telehealth platforms to monitor patients' health metrics remotely and adjust treatment plans as needed.
  • 24/7 Access: Providing patients with round-the-clock access to medical advice and support through telehealth services, ensuring they feel supported throughout the trial.


By integrating technology into the clinical trial process, researchers can improve patient engagement, streamline communication, and offer more flexible participation options, all of which contribute to higher retention rates and more successful trial outcomes.


Building Trust and Rapport with Participants


Establishing Strong Relationships Between Patients and Trial Staff


Building trust with participants is crucial for maintaining engagement and retention. Effective strategies include:


  • Personalized Interaction: Assigning dedicated trial coordinators to provide personalized attention and support to each participant.
  • Consistent Communication: Maintaining regular, open lines of communication between patients and trial staff to address any questions or concerns promptly.
  • Empathy and Understanding: Showing empathy and understanding towards participants’ experiences and challenges during the trial.


Ensuring Transparency and Honesty in Trial Procedures and Expectations


Transparency in clinical trials builds trust and encourages continued participation. Key practices include:


  • Clear Information: Providing detailed and comprehensible information about the trial's purpose, procedures, risks, and benefits from the outset.
  • Open Dialogue: Encouraging open discussions about the trial’s progress, any changes in procedures, and what participants can expect moving forward.
  • Informed Consent: Ensuring that the informed consent process is thorough, with opportunities for participants to ask questions and fully understand their involvement.


Recognizing and Addressing Patient Concerns Promptly


Promptly addressing patient concerns is essential for maintaining trust and ensuring a positive trial experience. Effective strategies include:


  • Active Listening: Paying close attention to participants' feedback and concerns, demonstrating that their input is valued.
  • Timely Responses: Providing quick and effective responses to any issues or questions that arise during the trial.
  • Continuous Support: Offering continuous support throughout the trial, including access to healthcare professionals and resources to help manage any adverse effects or difficulties.


By fostering strong relationships, ensuring transparency, and promptly addressing concerns, clinical trial teams can build trust and rapport with participants, significantly enhancing patient retention and overall trial success.


Offering Incentives and Recognition


Providing Financial Compensation or Reimbursements


Financial incentives can significantly improve patient retention by reducing the financial burden associated with participation. Effective strategies include:


  • Compensation for Time and Effort: Offering monetary compensation for time spent and effort made by participants during trial visits and procedures.
  • Travel Reimbursements: Providing reimbursements for travel expenses to and from the trial site, including public transportation fares, mileage, and parking fees.
  • Loss of Income Coverage: Compensating for any lost wages if participation requires taking time off work.


Offering Non-Monetary Incentives


Non-monetary incentives can also be powerful motivators for patient retention. Examples include:


  • Health Check-Ups: Offering free health check-ups or regular medical evaluations to monitor participants’ overall health.
  • Free Medications: Providing free access to the trial medication and possibly other related treatments during and after the trial period.
  • Access to Health Resources: Granting access to health resources such as dietary consultations, fitness programs, or wellness workshops.


Recognizing Patient Contributions and Milestones


Acknowledging and celebrating participants' contributions helps in maintaining their engagement and motivation. Effective practices include:


  • Certificates of Participation: Providing certificates or letters of appreciation to acknowledge participants’ involvement in the trial.
  • Milestone Celebrations: Celebrating key milestones, such as the completion of significant trial phases or patient anniversaries within the study.
  • Participant Events: Hosting events or gatherings to recognize and thank participants, providing them with an opportunity to connect with other participants and trial staff.


By offering both financial and non-monetary incentives and recognizing participants' contributions, clinical trials can foster a positive and motivating environment, significantly enhancing patient retention and overall trial success.


Monitoring and Adapting Retention Strategies


Regularly Tracking Retention Metrics and Patient Feedback


To ensure high retention rates, it’s crucial to monitor various metrics and gather patient feedback consistently. This involves:


  • Retention Rates: Keeping a close eye on retention rates at different stages of the trial to identify trends or potential issues.
  • Patient Satisfaction Surveys: Conducting regular surveys to gauge patient satisfaction and identify areas for improvement.
  • Feedback Mechanisms: Establishing channels for patients to provide feedback easily, such as suggestion boxes, online forms, or dedicated email addresses.


Identifying and Addressing Retention Challenges Promptly


Early identification and swift resolution of challenges are key to maintaining high retention rates. Effective strategies include:


  • Data Analysis: Analyzing collected data to pinpoint specific issues causing patient dropout, such as procedural complexities, side effects, or logistical difficulties.
  • Patient Interviews: Conducting interviews with patients who are at risk of dropping out to understand their concerns and address them directly.
  • Problem-Solving Teams: Forming dedicated teams to tackle retention issues, ensuring quick and efficient solutions to any problems identified.


Adjusting Strategies Based on Real-Time Data and Feedback


Adaptability is crucial in patient retention strategies. By using real-time data and patient feedback, clinical trial teams can make necessary adjustments to improve retention. This involves:


  • Dynamic Protocol Adjustments: Modifying trial protocols based on ongoing feedback to reduce patient burden and improve convenience.
  • Communication Enhancements: Updating communication strategies to address any identified gaps or misunderstandings.
  • Incentive Modifications: Tweaking incentive programs to better meet patient needs and preferences, ensuring they remain motivated and engaged.


By continuously monitoring and adapting retention strategies, clinical trials can maintain high levels of patient engagement and retention, ultimately leading to more reliable and successful trial outcomes.


Case Studies and Examples


Successful Patient Retention Strategies in Real-World Clinical Trials


Case Study 1: Oncology Trial


  • Trial Overview: A large-scale oncology trial focused on a new cancer treatment.
  • Strategies Used:
  • Flexible Scheduling: Offered weekend and evening appointments to accommodate patients' work schedules.
  • Comprehensive Support Services: Provided transportation and childcare services to alleviate logistical challenges.
  • Patient Education: Implemented regular educational sessions to ensure patients fully understood the trial’s purpose, procedures, and potential benefits.
  • Outcome: Achieved a 95% retention rate, significantly higher than the industry average for oncology trials.


Case Study 2: Diabetes Management Trial


  • Trial Overview: A clinical trial assessing the efficacy of a new diabetes management device.
  • Strategies Used:
  • Digital Engagement Tools: Utilized a mobile app for daily reminders, progress tracking, and virtual consultations.
  • Patient Feedback Loop: Established a feedback system where patients could voice concerns and suggestions, leading to continuous improvements in the trial process.
  • Community Building: Created a community support group for participants, fostering a sense of camaraderie and mutual support.
  • Outcome: Retention rate exceeded 90%, with patients reporting high levels of satisfaction and engagement.


Lessons Learned from Trials with High Retention Rates


  • Importance of Flexibility: Offering flexible scheduling and accommodating patients’ personal needs can significantly enhance retention.
  • Support Services: Providing additional support such as transportation, childcare, and patient education can reduce barriers to participation.
  • Continuous Engagement: Regular communication and the use of digital tools to keep patients informed and engaged are critical.
  • Feedback Mechanisms: Establishing robust feedback mechanisms allows for timely identification and resolution of issues, improving the overall patient experience.


Strategies to Avoid Based on Past Retention Challenges


  • Rigid Scheduling: Strict, inflexible schedules can lead to patient dropouts, especially among those with demanding personal or professional obligations.
  • Lack of Communication: Insufficient or unclear communication can result in misunderstandings and decreased patient trust and engagement.
  • Inadequate Support: Failing to provide necessary support services (e.g., transportation, childcare) can create significant barriers to participation.
  • Ignoring Patient Feedback: Neglecting to consider patient feedback can lead to unresolved issues and dissatisfaction, increasing the likelihood of dropout.


By learning from successful cases and avoiding common pitfalls, clinical trials can develop and implement effective patient retention strategies, ensuring higher retention rates and more reliable trial outcomes.


Recap of key points and best practices for patient retention Emphasis on the importance of diverse and representative participant pools Encouragement for ongoing innovation and collaboration in recruitment strategies


Recap of Key Strategies for Patient Retention 


Successfully retaining patients in clinical trials requires a multi-faceted approach:


  • Building a Patient-Centric Trial Design: Simplifying protocols, reducing patient burden, and incorporating patient feedback.
  • Effective Communication Strategies: Maintaining clear and consistent communication, providing regular updates, and educating patients about the trial.
  • Enhancing the Participant Experience: Creating a supportive environment, offering flexible scheduling, and providing additional support services.
  • Utilizing Technology for Engagement: Leveraging digital tools and telemedicine to facilitate patient monitoring and communication.
  • Building Trust and Rapport with Participants: Establishing strong relationships, ensuring transparency, and addressing concerns promptly.
  • Offering Incentives and Recognition: Providing financial and non-monetary incentives and recognizing patient contributions.
  • Monitoring and Adapting Retention Strategies: Regularly tracking retention metrics, addressing challenges promptly, and adjusting strategies based on feedback.


Emphasis on the Importance of Patient Engagement and Retention:


Patient engagement and retention are crucial for the success of clinical trials. High retention rates lead to more reliable and comprehensive data, which in turn accelerates the development of safe and effective treatments. Ensuring that participants feel valued, informed, and supported throughout the trial process is essential.


Encouragement for Ongoing Innovation and Patient-Centric Approaches in Clinical Trials:


Innovative and patient-centric approaches are key to improving retention rates. By continuously seeking new methods to enhance the participant experience and adapting to patient needs, clinical researchers can foster a more inclusive and effective trial environment.


Encouragement for Clinical Researchers to Prioritize Patient Retention:


Clinical researchers should prioritize patient retention as a critical component of trial design and execution. By implementing best practices and learning from successful case studies, researchers can significantly improve retention rates and overall trial success.


Invitation to Share Experiences and Best Practices in Patient Retention:


We encourage clinical researchers, trial coordinators, and healthcare professionals to share their experiences and best practices in patient retention. By collaborating and learning from each other, we can collectively enhance retention strategies and outcomes.


Emphasis on the Collective Effort Needed to Improve Retention Rates in Clinical Trials: 


Improving retention rates requires a collective effort from all stakeholders involved in clinical trials, including researchers, healthcare providers, patients, and regulatory bodies. By working together and prioritizing patient needs, we can ensure that clinical trials are more effective, efficient, and ultimately beneficial to patient care.


In conclusion, effective patient retention strategies are essential for the success of clinical trials. By adopting a patient-centric approach, leveraging technology, and continuously innovating, we can improve retention rates and contribute to the development of new and better treatments for various health conditions. Let's work together to prioritize patient retention and make clinical trials more inclusive and successful.



By Dr. Ahmed Donia August 13, 2024
Notable Labs is revolutionizing cancer treatment with its Predictive Precision Medicine Platform (PPMP), which simulates therapies and predicts patient responses with 95% accuracy. This groundbreaking technology leverages artificial intelligence and machine learning to generate extensive datasets from patient samples, enabling tailored treatments for each patient. In pediatric leukemia, precision diagnostics like next-generation sequencing enhance risk stratification, targeted therapies, and personalized treatment plans, potentially improving survival rates and quality of life. Notable's PPMP has shown success in predicting drug responses, such as achieving 100% accuracy in predicting clinical responses to venetoclax with decitabine in Acute Myeloid Leukemia. Rather than commercializing PPMP as a standalone product, Notable focuses on using its capabilities to enhance drug development, fast-track clinical trials, reduce risks, and improve patient outcomes by targeting responsive populations.
By Dr. Anjaney Kothari August 13, 2024
Combination therapy in cancer treatment involves using multiple therapeutic agents to target various aspects of the disease, offering improved patient outcomes. Notable Labs is leading advancements in this field, exemplified by its collaboration with Syros Pharmaceuticals to develop a predictive test for a combination therapy against non-acute promyelocytic leukemia (APL) acute myeloid leukemia (AML). Notable’s Predictive Precision Medicine Platform (PPMP) uses ex vivo drug sensitivity screening to predict patient responses to treatments, enhancing the effectiveness and safety of combination therapies. Despite current commercial challenges, Notable is focused on refining and expanding its technology, ensuring seamless integration into healthcare systems.
By Conor Prendergast August 13, 2024
Notable Labs is a biotech startup revolutionizing cancer treatment through its innovative Precision Predictive Medicine Platform (PMPP), leveraging data and technology to identify the most effective therapies for each patient. Founded by Matthew De Silva after his father's glioblastoma diagnosis, Notable Labs combines De Silva's finance background with the medical expertise of CEO Dr. Thomas Bock. The team includes esteemed professionals like Dr. Joseph Wagner, Dr. Glenn Michelson, and Scott McPherson, who collectively bring decades of experience in biotech, clinical trials, and financial strategy. Notable Labs partners with renowned hospitals and employs cutting-edge drug screening technology to provide personalized, data-driven treatment plans, significantly improving patient outcomes. With a dedicated and diverse team, Notable Labs stands at the forefront of precision oncology, offering hope and new possibilities for cancer patients worldwide.
By Divya Narasimhan August 13, 2024
Notable Labs' Predictive Precision Medicine Platform (PPMP) is revolutionizing pediatric leukemia treatment by leveraging advanced machine learning to predict the most effective therapies with 95% accuracy, as demonstrated in a Stanford study. This innovative approach tailors treatments to each patient's unique cancer profile, significantly improving outcomes for rare and aggressive leukemia types like pediatric acute myeloid leukemia (pAML) and juvenile myelomonocytic leukemia (JMML). Notable Labs' collaborations with leading institutions and use of high-throughput screening have enabled the rapid identification of effective drug combinations and personalized therapies, providing hope for better survival rates and quality of life for young cancer patients. With its commitment to refining precision medicine and expanding its applications, Notable Labs is poised to transform cancer care, ensuring that every child receives the best possible treatment.
By Fabian Goguta August 13, 2024
Predictive precision medicine, which predicts the most effective treatment for each patient, is revolutionizing cancer care. Notable Labs leverages this approach to improve cancer treatment by identifying optimal therapies for individual patients. According to a 2020 Stanford study, Notable's Predictive Medicine Platform (PMP) accurately predicted patient response to interventions in over 85% of cases. This technology analyzes how cancer cells respond to various treatments using flow cytometry and machine learning algorithms, providing actionable insights quickly. Notable Labs' collaborations with leading institutions have demonstrated significant success in treating pediatric leukemia, particularly rare and aggressive forms like pAML and JMML. By partnering with renowned medical centers and advancing the use of predictive diagnostics, Notable Labs is at the forefront of transforming pediatric oncology and improving outcomes for young patients.
By Kathleen Mackay July 29, 2024
Notable Labs is transforming cancer treatment with its innovative combination therapy approach. By leveraging its Predictive Precision Medicine Platform (PPMP), Notable identifies optimal drug combinations tailored to individual patients. This methodology aims to reduce the development of resistant cancer cells and allows each drug to be used at its best dosage without intolerable side effects. The platform has shown impressive predictive accuracy in clinical trials, particularly for pediatric leukemia. Notable's commitment to precision medicine offers new hope for patients with high unmet medical needs, driving better treatment outcomes and enhancing quality of life.
By Scott Smith July 29, 2024
Notable Labs is revolutionizing cancer treatment with its innovative approach to combination therapy, which targets multiple cancer pathways simultaneously. Their Predictive Precision Medicine Platform (PPMP) leverages advanced data analysis and machine learning to identify the most effective drug combinations for individual patients. By using high-throughput screening and bio-simulation, Notable Labs accelerates drug development, reduces costs, and improves clinical trial success rates. This approach promises significant improvements in patient outcomes, particularly for pediatric leukemia, by providing personalized, effective treatments and minimizing side effects.
By Ayushi Hisaria July 29, 2024
Notable Labs' cutting-edge diagnostic technology, boasting a 95% prediction accuracy per a Stanford study, is set to revolutionize pediatric leukemia treatment by identifying the most effective therapies. Their mission centers on advancing precision diagnostics to enhance therapy efficacy for young patients. Utilizing high-throughput screening and machine learning, Notable's platform offers tailored treatment plans, significantly improving outcomes for rare and aggressive forms of leukemia. This approach holds promise for personalized medicine, ensuring each child receives optimal, life-saving care.
By Syeda Abeer Iqbal July 29, 2024
Notable Labs is transforming pediatric leukemia treatment with its Predictive Precision Medicines Platform (PPMP), which boasts a 97% predictive precision. This platform rapidly identifies the most effective treatments for individual patients, significantly reducing the time and cost of cancer therapy. Notable Labs focuses on personalized medicine, combining high-throughput screening and machine learning to predict patient responses and tailor treatments accordingly. Their innovative approach has shown promising results in clinical validation studies, offering new hope for improving outcomes in pediatric leukemia.
By Daniel Ferry July 29, 2024
Notable Labs is a clinical-stage precision oncology company developing new cancer therapies identified by its Predictive Medicine Platform (PMP), today announced progress for the Phase 2 volasertib program following receNotable Labs is a clinical-stage precision oncology company developing new cancer therapies identified by its Predictive Medicine Platform (PMP), today announced progress for the Phase 2 volasertib program following receipt of “Clearance to Proceed” from the FDA and agreement on the dosing plan for its Phase 2 clinical trial. With trial start-up activities launched in the first quarter of this year, Notable intends to initiate enrollment in the Phase 2 study for PMP-enabled development of volasertib for relapsed refractory (R/R) acute myeloid leukemia (AML) in the coming months.ipt of “Clearance to Proceed” from the FDA and agreement on the dosing plan for its Phase 2 clinical trial. With trial start-up activities launched in the first quarter of this year, Notable intends to initiate enrollme
More Posts
Share by: